Evidence guide
Is remote patient monitoring cost-effective, and for whom?
Often, yes, but the answer depends on the condition and the program. Economic evaluations of hypertension RPM generally favored monitoring, and a hypertension program at NYU Langone Health reported a positive average return for the provider. This guide separates practice ROI, payer spending and cost-effectiveness so you can test the assumptions that drive each result for a combined RPM+CCM service.
Summary by Vironix Health · Source review: November 12, 2026
How we select and interpret evidence
Curation cutoff: November 12, 2026
What to take away
- Economic evaluations of hypertension RPM generally favored monitoring; heart-failure and COPD results varied by setting and severity.
- A published hypertension RPM program reported a positive average provider return; its sensitivity analysis shows which assumptions drive the result.
- Practice ROI, payer savings and cost-effectiveness are different questions; cost a combined RPM+CCM service as one program, including what the service fee already covers.
Three financial questions that need different evidence
Question | What to measure | Evidence boundary |
|---|---|---|
Is this financially sustainable for our practice? | Collected program revenue, agreed service fees and costs borne directly by the practice. | The Zhang analysis concerns one provider program; its sensitivity analysis includes losses. |
Does it reduce payer spending? | Total spending compared with an alternative, including program payments. | The CMS CCM report separates gross and net estimates; its spending result changes under sensitivity analyses. |
Do health gains justify the additional cost? | Incremental costs and health outcomes over a stated horizon. | The De Guzman review found variation by condition and setting, not one transferable RPM return. |
Supporting studies: Donglan S Zhang (2026) [1]; John Schurrer (2017) [2]; Keshia R De Guzman (2022) [3]
Start with the economic perspective
De Guzman’s review found variation across conditions and settings. Gavan’s review addresses patient-reported mobile monitoring and excludes measurements requiring additional devices, such as BP cuffs or spirometers, as well as passive wearable monitoring. A symptom-monitoring economic model is not direct evidence for the margin of a connected BP-cuff service.
Supporting studies: Keshia R De Guzman (2022) [3]; Sean P Gavan (2025) [4]
Cost the combined pathway as one program
For a proposed RPM+CCM service, identify which activities are included: monitoring, outreach, adherence support, care-plan follow-up, coordination and clinical review. Match the costs to the agreed scope and avoid double-counting shared work already included in the service fee. This is a planning interpretation, not a return estimated by the studies.
Zhang’s RPM analysis and the CMS CCM evaluation concern different programs and economic perspectives; their results cannot be added to estimate a combined-program return.
Supporting studies: Donglan S Zhang (2026) [1]; John Schurrer (2017) [2]
Separate practice margin from patient benefit
Zhang’s final journal article evaluates a provider program’s costs and estimated reimbursement. Its sensitivity analysis includes losses. We use the journal abstract only and omit financial magnitudes whose time horizon could not be verified there; the earlier preprint is not counted separately.
Supporting studies: Donglan S Zhang (2026) [1]
Account for fees and uncertain denominators
The CMS report separates gross and net savings, with important sensitivity to analysis choices. Clark’s practice study has unresolved cost-unit and cohort inconsistencies. Neither justifies inserting a generic savings percentage into a local business case.
Supporting studies: John Schurrer (2017) [2]; Bennett W. Clark (2026) [5]
Virtual visits change different people’s costs
Lavin’s pandemic review reports heterogeneous findings across patient, payer and health-sector perspectives. Lower patient costs can coexist with higher telehealth spending and little change in total spending. Caffery found only a small economic evidence base comparing video with telephone. These results do not provide a transferable RPM ROI estimate.
Supporting studies: Lauren Lavin (2025) [6]; Liam J Caffery (2025) [7]
Evidence gaps
Economic studies use different comparators, costing methods and time horizons. Historical reimbursement assumptions are not current payment advice. The selected sources cannot provide a universal break-even enrollment target or a guaranteed return.
Practical interpretation
Interpret a study’s costs in the context of its delivery model. An internally staffed program may pay separately for devices, review, outreach and administration. A managed service may include those activities within its fee. Compare the service scope, implementation terms and any work handled directly by the practice; avoid counting the provider’s internal costs again when they are already included in the fee.
Use the proposed agreement and practice-specific assumptions to evaluate revenue, participation and collections. Review patient outcomes and experience alongside the financial result. Published economic studies provide context; they do not determine a particular service’s pricing, invoicing schedule or staffing arrangement.
The workflow guide explains coordination with a managed team. See Vironix RPM services to discuss the delivery model and commercial arrangements for your practice.
References
- Program cost and return on investment analysis of remote patient monitoring for hypertension management in the cardiology department of a large healthcare system
Donglan S Zhang; Laure Millet; Brandon K Bellows; Sarah Lee; Devin Mann. Journal of Telemedicine and Telecare. 2026.
Original source - Evaluation of the Diffusion and Impact of the Chronic Care Management (CCM) Services: Final Report
John Schurrer; Ann O'Malley; Claire Wilson; Nancy McCall; Neetu Jain. Mathematica Policy Research report for CMS. 2017.
Original source - Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review
Keshia R De Guzman; Centaine L Snoswell; Monica L Taylor; Leonard C Gray; Liam J Caffery. Value in Health. 2022.
Original source - Active remote monitoring of long-term conditions with mobile devices: a systematic review of cost-effectiveness analyses
Sean P Gavan; Katherine Payne; William G Dixon; Sabine N van der Veer; Alexander C T Tam; Nick Bansback. npj Digital Medicine. 2025.
Original source - Cost impact of chronic care management services in a large multi-specialty practice: A pragmatic outcomes study
Bennett W. Clark; Jacob Webster; Souvik Chatterjee; Michael D. Finch. PLOS One. 2026.
Original source - The Effect of Telehealth on Cost of Health Care During the COVID-19 Pandemic: A Systematic Review
Lauren Lavin; Heath Gibbs; J Priyanka Vakkalanka; Sara Ternes; Heather S Healy; Kimberly A S Merchant; Marcia M Ward; Nicholas M Mohr. Telemedicine and e-Health. 2025.
Original source - Telephone versus video consultations: A systematic review of comparative effectiveness studies and guidance for choosing the most appropriate modality
Liam J Caffery; Soraia De Camargo Catapan; Monica L Taylor; Jaimon T Kelly; Helen M Haydon; Anthony C Smith; Centaine L Snoswell. Journal of Telemedicine and Telecare. 2025.
Original source